News Articles 81 - 90 of 160

22
Jun
Dame Shelia Sherlock Research Prize 2017 - apply now - deadline 4th August 2017
News Type: BASL News

Deadline: Friday 4th August 2017

Each year BASL presents the Dame Sheila Sherlock research prize, one of the highlights of the annual meeting. This prize is awarded annually to recognise the enormous contribution of Dame Sheila Sherlock to the development of Hepatology as a discipline in its own right.

When Dr Sherlock started her medical career, little was known about liver disease. Her work helped to establish hepatology as a medical specialty. She pioneered the use of needle liver biopsy, which had been used purely as a research tool, based on the technique of Sir John McMichael; this improved understanding of the pathology of liver disease and is used in the diagnosis of liver diseases today. The liver unit that she set up at the Royal Free Hospital became the centre for both research into liver disease and the education of trainees in the specialty.

Dame Sheila was involved in the foundation of the British Liver Club in 1961, which subsequently evolved into The British Association for the Study of the Liver (BASL). She was one of our past presidents and the first recipient of The BASL Distinguished Service Award.

In keeping with Dame Sheila’s enthusiasm for fostering young researchers, this eponymous research prize is awarded to young investigators without substantive posts in either medicine or science for their research contributions in the field of Hepatology.

The winner of the award will deliver a lecture presenting their research during the Annual Meeting, 20-22 September 2017. This year the prize is free registration to the meeting, a place at the Annual Dinner at Warwick Castle and £1,000.

To apply, please send one A4 sheet outlining the research and another A4 sheet detailing the related publications.

Please send submissions to steve@basl.org.uk before the deadline of midday on Friday 4th August 2017. 

22
Jun
Andy Burroughs Young Investigator Award 2017 - apply now - deadline 4th August 2017
News Type: BASL News

Deadline: Friday 4th August 2017

The Andy Burroughs Young Investigator Award was set up in honour of the late Professor Andrew Burroughs, who sadly passed away in March 2014. Professor Burroughs was an eminent and world renowned Professor of Hepatology and Consultant Physician/Hepatologist and among his many achievements was his significant contribution to liver transplantation.

This year the award will take place during the BLTG Transplant Meeting at Warwick Conference Centre, 19-20 September 2017.

This prize is awarded to young investigators, scientific or clinical, who are in training or within 2 years of taking up consultant positions (or equivalent) and the winner will deliver the prize lecture at the Meeting which will be being held at 11.30-12.10 on Tuesday 19th September, and will also receive free registration to the meeting and £1,000.

To apply, please send one A4 sheet outlining the research and another A4 sheet listing up to 5 related publications.

Please send submissions to steve@basl.org.uk before the deadline of midday on Friday 4th August 2017.

22
Jun
BASL Annual Meeting - Warwick Conference Centre - 20th - 22nd September 2017 - Registration now Open
News Type: BASL News

Please join us at Warwick University for the BASL 2017 Annual Conference where all of us interested in liver disease will share time whether we are clinicians, nurses, basic scientists, pharmacists, working in industry or students.

BASL follows seamlessly from the third meeting of the British Liver Transplant Group (BLTG), making it easy for the many delegates who want to attend both conferences. BLTG as ever includes the ‘Williams-Calne Lecture’, given this year by Professor Peter Friend (Oxford). An additional highlight is the state of the art lecture by Professor Geoff McCaughan (Sydney).

The BASL conference opens after lunch on Wednesday and will explore clinical and liver related aspects of senescence with a distinguished international faculty. A highlight of the meeting will be the state of the art lecture by Professor Judith Campisi (Buck Institute, California).

The second day has two streams: first, the interaction between the Liver and the Gut and second, the named lectures. These include the Ralph Wright Lecture (Professor John O’Grady) the British Liver Trust Lecture (Dr. Mary Ramsay), the inaugural Alex Mowat Lecture (Dr. Sue Beath) and the annual Dame Sheila Sherlock Prize Lecture.

The main poster session is on Wednesday evening with supper provided and the conference dinner (supported by BASL) is at Warwick Castle, a stunning venue, on Thursday evening.

The Nurses Day runs in parallel to the BASL meeting on Thursday 21st September and this year has especial importance as it will be celebrating the launch of the newly formed British Liver Nurses Association following a merger of the BLNF & the BASLNF. This day promises to deliver exciting and inspiring sessions for all nurses working within Hepatology, with the programme including a wide range of topics relating to liver disease and its associated issues and challenges.

There are considerable 'Early Bird' discounts available for BASL and BASLNF members and the deadline for early bird registration is Monday 31st July 2017.

View the Programme and Register now on the BASL Annual Meeting website for both meetings by clicking > here.

22
Jun
Enough alcohol sold in England for every drinker to consume 50% more than guideline levels
News Type: BASL News

New figures published today reveal that enough alcohol is being sold in England and Wales for every drinker to consume 21 units of alcohol a week – far more than the low-risk level of 14 units per week for both men and women recommended by the UK's chief medical officers.

The figures reveal that the situation is even worse in Scotland, with enough alcohol being sold for every drinker to consume 24 units a week.

The data was released by NHS Health Scotland, who also looked at consumption in England and Wales in order to compare patterns across the UK.

Roughly speaking, a regular-strength pint of beer and a 175ml glass of wine both contain 2 units of alcohol.

To tackle high levels of alcohol-related deaths and illness, Scotland is set to introduce a minimum unit price for alcohol, which would raise the price of the cheapest alcohol products which do the most harm. The Scottish government passed minimum unit pricing over 5 years ago, though implementation of the measure has so far been delayed due to legal challenges from the alcohol industry.

Minimum unit pricing formed part of the Westminster government's alcohol strategy in 2012, though has yet to be implemented in England and Wales.

Responding to the publication of the figures, Professor Sir Ian Gilmore, chair of the Alcohol Health Alliance UK (AHA), said:

"These figures are shocking and show why minimum unit pricing is needed in Scotland, as well as in the rest of the UK.
As a result of the legal challenges from the alcohol industry, lives will undoubtedly have been lost in Scotland. We hope and expect minimum unit pricing to be ruled legal in the final court hearing in this case in July, so that implementation in Scotland can follow.
If minimum unit pricing is ruled legal in Scotland, a decision by Westminster to delay would be a death sentence for some, including many from the lowest income groups. The evidence is already clear - minimum unit pricing saves lives, prevents illness and lowers hospital admissions."

About the Alcohol Health Alliance UK
The Alcohol Health Alliance UK (AHA) is a group of over 50 organisations including the Royal College of Physicians, Royal College of GPs, British Medical Association, Alcohol Concern and the Institute of Alcohol Studies. The AHA works together to:

· Highlight the rising levels of alcohol-related health harm
· Propose evidence-based solutions to reduce this harm
· Influence decision makers to take positive action to address the damage caused by alcohol misuse

For further information, please contact Matt Chorley, the AHA's Policy and Communications Officer, at matt.chorley@rcplondon.ac.uk or on 0203 075 1726.

16
Jun
NICE Committee member recruitment – Alcohol interventions in schools - deadline 17:00 23 June 2017
News Type: BASL News

NICE are recruiting members for one of their guideline Committees.

They are looking for experts on Alcohol to join their Public Health committee to update a guideline on Alcohol interventions in schools and need people with a professional or practitioner background in the topic.

Further details can be found on the NICE website;  https://www.nice.org.uk/get-involved/join-a-committee .

The deadline for applications has been extended to 17:00, Friday 23rd June 2017.

If you have any questions about Committee membership or the recruitment process, please contact PHMember@nice.org.uk .

15
Jun
NHS England - seeking an organisation to appoint as a patient/public member to its Specialised Commissioning: Hepatobiliary and Pancreas services Clinical Reference Group (CRG).
News Type: BASL News

NHS England is seeking an organisation to appoint as a patient / public member to its Specialised Commissioning: Hepatobiliary and Pancreas services Clinical Reference Group (CRG).

Scope of the Clinical Reference Group (CRG) covers: Hepatobiliary (HPB) services treat patients who have disorders of the liver, bile ducts and pancreas. A large volume of HPB services are delivered in local hospitals but, because of the complexity and high cost of care, delivery in conjunction with, or at, specialist tertiary centres is necessary.

This Clinical Reference Group (CRG) covers:
• the management of people with serious complications of cirrhosis (about 3,000 cases each year)
• services for people with complex liver, biliary and pancreatic surgery (about 5,000 cases each year), including surgery for HPB cancers
• this CRG works with the Infectious Diseases CRG on services for hepatitis C (about 2,000 new cases each year).

For more information click here - https://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-a/a02/

CRGs bring together groups of clinicians, commissioners, public health experts, patients and carers. They use their specific knowledge and expertise to advise NHS England on the best ways that specialised services should be provided. CRGs provide advice on the development of service specifications, commissioning policies, identifying innovation and improving quality.

There will be an honorarium of £75 per half day or £150 per day (for those people not representing or supported by an organisation). This is in line with the NHS England policy.

Recruitment is now live. If you are interested in applying for one of these roles, or to find out more, please email england.voice-crg@nhs.net and request an application pack.

More information about the different Clinical Reference Groups can be found on the NHS England website > here.

02
Jun
Europe and Canada Practice to Policy Health Awards Programme - Applications Now Open
News Type: BASL News

The Europe and Canada Practice to Policy Health Awards Programme is now open. 

More information can be found here; Download EUCA_Practice-to-Policy_website-link-card-revised-approved-UK.pdf .

APPLY ONLINE via www.interceptpracticetopolicy.com .

The closing date is 30th June 2017.

11
May
AHA comment: Poorest people at greater risk of harm from heavy drinking, study finds
News Type: BASL News

Responding to the University of Glasgow study published on Wednesday 10th May 2017 in The Lancet Public Health which found that drinking heavily is more harmful to the poorest people in society, Professor Sir Ian Gilmore, chair of the Alcohol Health Alliance UK (AHA), said:

“The findings in this study are worrying if not altogether surprising. It is clear that the way alcohol is being sold and promoted in Scotland and elsewhere in the UK is harming some of the most vulnerable people in society.

“On the other hand, we know what needs to be done, in particular to tackle the scourge of cheap alcohol. In real terms, alcohol is 60% cheaper than it was in 1980 and measures like strength based pricing would disproportionately benefit the poorest groups, in terms of reduced deaths, illness and hospital admissions. Studies have shown that 82% of the lives saved through minimum unit pricing would come from the lowest income groups.

“Overall, in the first year alone minimum unit pricing in Scotland is expected to save 60 lives and lead to 1,600 fewer hospital admissions and 3,500 fewer crimes, yet its introduction has been held up for years by alcohol industry legal challenges.

“Importantly, minimum unit pricing would leave pub prices untouched, and moderate drinkers would spend only about £2.25 extra per year with a 50p minimum price.”

About the Alcohol Health Alliance UK

The Alcohol Health Alliance UK (AHA) is a group of over 50 organisations including the Royal College of Physicians, Royal College of GPs, British Medical Association, Alcohol Concern and the Institute of Alcohol Studies. The AHA works together to:
- Highlight the rising levels of alcohol-related health harm
- Propose evidence-based solutions to reduce this harm
- Influence decision makers to take positive action to address the damage caused by alcohol misuse

For further information, please contact Matt Chorley, the AHA’s Policy and Communications Officer, at matt.chorley@rcplondon.ac.uk or on 0203 075 1726.

04
May
Alcohol-related Hospital Admissions at Record High
News Type: BASL News

New figures released today show that hospital admissions due to alcohol are at their highest ever levels.

The data, summarised in a release from NHS Digital, shows that alcohol-related hospital admissions in England have increased by 64% over the last decade, with an extra 430,000 people being admitted due to alcohol-related causes in 2015/16 compared with 2005/06.

This takes the total number of alcohol-related hospital admissions to over 1.1 million in 2015/16.

Alcohol is linked to over 60 illnesses and diseases, including heart disease, liver disease and cancer. Figures from the local alcohol profiles for England show that admissions due to liver disease have gone up 57% over the last decade, and that the number of people diagnosed with alcohol-related cancer has increased 8%.

In contrast, separate data released today by the Office of National Statistics shows that the proportion of adults drinking is at its lowest level since 2005, with younger people more likely to be abstaining from alcohol. However, 7.8 million people admit to binge drinking on their heaviest drinking day.

In response to the figures, alcohol health experts called for more to be done in the UK to tackle the health harm done by alcohol.

Liver doctor Professor Sir Ian Gilmore, chair of the Alcohol Health Alliance UK (AHA), said:

“These figures show that the UK continues to have a dysfunctional relationship with alcohol."

"We know that over the long term, rates of binge drinking are falling, and more people are choosing to abstain from alcohol."

"Worryingly, however, these trends do not appear big enough to stop alcohol harm from continuing to rise, and the sharp increase in alcohol-related hospital admissions over the last few years means hundreds of thousands more people each year are experiencing the misery associated with harmful alcohol consumption."

"The data released today should be sobering reading for whoever wins the upcoming general election, and we would urge the next government to make tackling alcohol harm an immediate priority to save lives, reduce harm, and reduce the pressure on the NHS.”

The data is available via the following links.
NHS Digital: Statistics on alcohol – England, 2017
Office of National Statistics: Adult drinking habits in Great Britain 2005 to 2016
Local Alcohol Profiles for England

For further information, please contact Matt Chorley, the AHA’s Policy and Communications Officer, at matt.chorley@rcplondon.ac.uk or on 0203 075 1726.

03
May
Vacancy for a National HCC-UK Cancer Analyst - closing date 8 May 2017
News Type: BASL News

National HCC-UK Cancer Analyst
Circa £35,000 per annum (London) or £33,000 (Regional).
Full time for 2 years, in the first instance.

We are seeking an experienced cancer analyst to join an exciting new partnership between HCC-UK, the British Association for the Study of the Liver (BASL) and Public Health England (PHE). In this key role, you will be working to improve the outcomes for patients diagnosed with hepatocellular carcinoma (HCC) – the most common type of liver cancer.

You must have demonstrable skills in gathering, understanding, managing, evaluating and manipulating large amounts of data from a range of sources. You will be an excellent communicator, building strong relationships and working collaboratively with key stakeholders in order to obtain vital data.

You will undertake a detailed review of at-risk HCC patients with regard to age, sex, cirrhosis, aetiology of the underlying liver injury (if any); a considered review of treatment effects on survival, adverse events and cost; and an overall examination of the relationship between these and the outcomes.

Based within the National Cancer Registration and Analysis Service (NCRAS) in PHE, you will work closely with a Clinical Research Fellow, representatives from BASL and HCC-UK, and other UK professionals with similar interests. You must be comfortable working in a remote-managed setting.

How to apply:
Please send your CV and a supporting statement together as one document of no more than five pages to Professor Graeme Alexander (g.alexander@ucl.ac.uk ) or Dr Aileen Marshall (aileen.marshall@nhs.net ). Your supporting statement should explain how you think you meet the requirements of the role and person specification in no more than one side of typed A4. If you require further information, please email Prof Alexander.

Download HCC PHE Cancer Analyst JD Final 210417.pdf

Closing Date: 8th May 2017
First Interview: To be held in May 2017

About the partnership
HCC-UK is a multidisciplinary UK-wide group interested in all facets of management and sits currently under the BASL umbrella. The collaboration between BASL, HCC-UK and PHE proposes to increase our understanding of HCC in England & Wales and to address many of the issues experienced by this patient group. The partnership aims to ensure that liver services in the UK deliver the best available therapy efficiently to all patients with HCC regardless of socioeconomic status or liver centre. The focus will be on extensive use of available retrospective data in the first instance, with prospective data collection a long term intention. The group will also include expertise in health economics for a cost evaluation of HCC, per se, and treatment of this condition in England & Wales.